Viemed Healthcare Inc (TSX/NASDAQ: VMD) is a home medical equipment company that specializes in post-acute respiratory care services in the United States. Revenue comes from equipment rental and related services reimbursed by Medicare, Medicaid, Medicare Advantage plans, and commercial insurers. The company operates exclusively through U.S. subsidiaries, serving patients with chronic respiratory conditions through a technology-enabled, home-based clinical care and chronic disease management model. As of Q4 FY2025 (quarter ended December 31, 2025), Viemed served 12,259 ventilator patients and 34,528 PAP therapy patients. Full-year FY2025 revenue totaled $270.3 million across the four quarters ended December 31, 2025, with gross margins running 56 to 58 percent. Reimbursement policy from the Centers for Medicare and Medicaid Services is a primary demand driver, including a final National Coverage Determination on noninvasive positive pressure ventilation issued June 9, 2025. The company was incorporated December 14, 2016 under British Columbia's Business Corporations Act and reports to the SEC on Form 10-K.

Revenue model

Fee-for-service and equipment rental revenue reimbursed by Medicare, Medicaid, Medicare Advantage plans, and commercial insurers. Reimbursement rates are set by CMS coverage determinations and negotiated commercial payor contracts. The company is dependent on a limited number of payors, which the 10-K (filed 2026-03-04) identifies as a material concentration risk.

Products and services

Home medical equipment and supplies focused on respiratory care, including noninvasive positive pressure ventilators (primary product line), PAP therapy devices, and associated clinical care services. The company describes its model as technology-enabled home-based care for chronic disease management, designed to treat patients at lower total cost than facility-based alternatives.

Customers and end markets

Patients with chronic respiratory conditions, including chronic obstructive pulmonary disease and related diagnoses requiring home ventilation or PAP therapy. End-market demand is driven by CMS coverage policy, physician prescribing patterns, and commercial insurer reimbursement decisions. As of December 31, 2025, the company served 12,259 ventilator patients and 34,528 PAP therapy patients (per 10-K filed 2026-03-04).

Value-chain role

Direct-to-patient provider of home medical equipment and respiratory care services. The company sits between equipment suppliers and the insured patient, managing clinical intake, equipment delivery, ongoing care coordination, and payor billing. It operates entirely within the United States through wholly owned subsidiaries.

Geographic exposure

United States only. All operations are conducted through U.S. subsidiaries. The parent company is incorporated in British Columbia, Canada, and files on both SEC and SEDAR+ (per 10-K filed 2026-03-04).

Source: SEC 10-K, filed 2026-03-04

Industry: Services-Misc Health & Allied Services, NEC Peers: AirSculpt Technologies Inc AKUMIN INC. ATI Physical Therapy, Inc. Aveanna Healthcare Holdings Inc GeneDx Holdings Corp CVS Health Corp Invitae Corp